Home » News » Currently Reading:

QuadraMed Names Duncan James CEO

July 27, 2009 News 9 Comments

image

QuadraMed announced this morning that Duncan W. James will become CEO of the company when it files its 10-Q report next week. He succeeds interim president and CEO James Peebles.

James was previously with McKesson Provider Technologies, where he was group president for Health Systems Solutions from 2000-2009. Previously, he was senior VP for consulting firm Scient and VP of marketing and product management with McKesson.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there are "9 comments" on this Article:

  1. I hope this helps pull QuadraMed out of the tailspin.

    They have good products and an appropriate vision. One of the few vendors with a single database for Closed Loop Medication Management…a huge challenge for many vendors.

    We are customers and they have historically really struggled with execution of the vision.

  2. Can hear it now . . . .

    We will be the largest EMR vendor. We can compete with Epic and win.

    Goodbye to the HIM and core Rev cycle business . . . . Even though it is they are only solutions worth keeping . .

    Can’t just sunset the Affinity stuff then acquire technology from Misys (who couldn’t make it work), slap a below average brand (QuadraMed) on it who has real challenges being in the public markets and expect that you are now a dominant Clinical CPOE and EMR vendor . . . .

  3. Duncan is a “cut to profitability” kind of guy. He is not a business builder nor one that employees are loyal to. Nor did customers care much for him. Would be very surprised if any of the quality people coming out of McKesson would be joining Quadramed.

  4. Wow, wonder what his non compete agreement was like with McKesson. How much is that going to cost Quadramed?

    Not a great person to work for at all

  5. Duncan James was involuntarily terminated by MCK 45 days before he showed up at QDHC . . or maybe he “voluntarily” resigned . . . regardless he didn’t leave because he wanted to . . . . you think the clinical focuses at MCK were great? Horizon clinicals = JOKE . . never worked and never will . . . can’t even interface to their own products . . . Duncan led the business unit . .

    Happy days ahead for +QDHC . . . . Doik . . .

  6. Death-Spiral with Duncan James at the helm. Since he took over – No new sales, sales pipeline empty, botched software releases, demoralized staff with his “cut to the bone” idea of leadership, and it goes on… But, to be fair, they hired this guy to be a chop-shop artist. HBOC is no doubt immensely relieved to see him gone. Another master-stroke by the Quadramed Board of Directors!







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Vaporware?: Secretary Shulkin: "the American healthcare system hasn’t yet figured out interoperability, but the VA can lead the wa...
  • Justa CIO: The reported go live date for McLaren Oakland is wrong. There are no dates set for activations for any locations. Post...
  • Brian Too: I admit I am partial to the quoted ICD-10-CM of "S07.9XXA Crushing injury of head, part unspecified, initial encounter....
  • Cosmos: As others in the comments section have pointed out before, GE's EMR for athletes is ironically a health record for the h...
  • HIT MD: I appreciate the thoughtful postings on this topic, particularly those by Ross Martin and LMNOP. I've never participate...
  • My Two Cents: Re: I wish we could all just get along and put the patient at the center of what we do. Yep, I get more and more disc...
  • bbc: Did you take the Hippocratic Oath in Med school? does the slightest thought of helping your patients concern you at all...
  • My Two Cents: I have a few concerns about the article Mr. Crane wrote on Drug Pricing Transparency and respectfully disagree and quest...
  • Brian Too: Aha! That makes more sense now. Thank you for clarifying....
  • So.....: Why not embed this functionality in to the patient portal and let the patient take on the leg work and the extra clicks?...

Sponsor Quick Links